tiprankstipranks
Trending News
More News >
Alembic Pharmaceuticals Limited (IN:APLLTD)
:APLLTD
India Market

Alembic Pharmaceuticals Limited (APLLTD) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

APLLTD Financial Forecast

APLLTD Earnings Forecast

Next quarter’s earnings estimate for APLLTD is ₹7.00 with a range of ₹7.00 to ₹7.00. The previous quarter’s EPS was ₹8.00. APLLTD beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.10% of the time in the same period. In the last calendar year APLLTD has Preformed in-line its overall industry.
Next quarter’s earnings estimate for APLLTD is ₹7.00 with a range of ₹7.00 to ₹7.00. The previous quarter’s EPS was ₹8.00. APLLTD beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.10% of the time in the same period. In the last calendar year APLLTD has Preformed in-line its overall industry.

APLLTD Sales Forecast

Next quarter’s sales forecast for APLLTD is ₹17.40B with a range of ₹17.40B to ₹17.40B. The previous quarter’s sales results were ₹17.70B. APLLTD beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.49% of the time in the same period. In the last calendar year APLLTD has Outperformed its overall industry.
Next quarter’s sales forecast for APLLTD is ₹17.40B with a range of ₹17.40B to ₹17.40B. The previous quarter’s sales results were ₹17.70B. APLLTD beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.49% of the time in the same period. In the last calendar year APLLTD has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
ICICI Securities Analyst forecast on IN:APLLTD
Unknown AnalystICICI Securities
Not Ranked
ICICI Securities
₹1,125₹925
Hold
2.33%
Upside
Reiterated
02/05/25
Alembic Pharmaceuticals (ALPM:IN) PT Lowered to INR925 at ICICI SecuritiesICICI Securities analyst Nisha Shetty lowered the price target on Alembic Pharmaceuticals (ALPM:IN) to INR925.00 (from INR1,125.00) while maintaining a Hold (3) rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
ICICI Securities Analyst forecast on IN:APLLTD
Unknown AnalystICICI Securities
Not Ranked
ICICI Securities
₹1,125₹925
Hold
2.33%
Upside
Reiterated
02/05/25
Alembic Pharmaceuticals (ALPM:IN) PT Lowered to INR925 at ICICI SecuritiesICICI Securities analyst Nisha Shetty lowered the price target on Alembic Pharmaceuticals (ALPM:IN) to INR925.00 (from INR1,125.00) while maintaining a Hold (3) rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

APLLTD Analyst Recommendation Trends

Rating
May 25
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
total
1
In the current month, APLLTD has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. APLLTD average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

APLLTD Stock Forecast FAQ

What is IN:APLLTD’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:APLLTD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:APLLTD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Alembic Pharmaceuticals Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is Alembic Pharmaceuticals Limited’s share price target?
      Currently, no data Available
      What do analysts say about Alembic Pharmaceuticals Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Alembic Pharmaceuticals Limited?
      To buy shares of IN:APLLTD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis